Proposed Directors of Tirupati Graphite explain why they have requisitioned an GM. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIlika Plc Regulatory News (IKA)

Share Price Information for Ilika Plc (IKA)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 27.00
Bid: 26.00
Ask: 28.00
Change: -0.50 (-1.82%)
Spread: 2.00 (7.692%)
Open: 27.50
High: 27.50
Low: 27.00
Prev. Close: 27.50
IKA Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

AGM Statement

30 Sep 2015 07:00

RNS Number : 6113A
Ilika plc
30 September 2015
 

 

Ilika plc

("Ilika" or the "Company")

 

AGM Statement

 

Ilika (AIM: IKA), the accelerated materials innovation company, will hold its Annual General Meeting today at 2pm at the offices of Eversheds LLP, One Wood Street, London, EC2V 7WS.

 

Ahead of the formal proceedings Graeme Purdy, CEO of Ilika, will provide the following update to shareholders:

 

Since the announcement of our final results in July, operations at Ilika have been dominated by the activities associated with the production of our solid-state batteries. In March 2015 we announced commencement of solid-state battery production, which enabled us to enter into a dialogue with our OEM partners on integration of the batteries with their products. The principal applications being addressed are wireless sensors for smart buildings, transport and medical devices. These interactions resulted in a set of performance targets being defined for each application. The performance targets have been translated into a development roadmap with intermediate milestones to be achieved along the way. The technical team has been working hard to achieve these milestones over the summer period and solid progress is being made towards commercialisation.

 

Ilika's portfolio of patents, covering its solid-state battery technology, has also made good progress. We reported in March that we had received a Notice of Allowance in the United States for one of the applications and an Intention to Grant in Europe for another. Both were jointly filed with Toyota. As expected, these patents went to formal grant in those jurisdictions in June and July respectively. Earlier this week, Ilika announced that it had also received notification of grant of one of these patents in China. In July, a further three patent applications covering other aspects of our battery technology were published. We expect further filings to result from the development work currently being undertaken.

 

In August we reported that the European Patent Office had upheld Ilika's opposition to a fuel cell catalyst patent from a US national lab. Ilika invests significant sums in creating intellectual property to underpin the company's licensing model. Potentially competitive filings are monitored closely and are challenged where appropriate. The patent revocation means that Ilika now enjoys freedom to operate the European patent covering our palladium-alloy based fuel cell catalyst. While the adoption rate of fuel cell technology has always been difficult to predict, the recent launch of vehicles like the Toyota Mirai signals an increased focus by OEM's on cost-reduction in readiness for the mass market. Ilika's patented fuel cell catalyst materials are currently under evaluation by global car manufacturers and Tier 1 suppliers.

 

Also of note has been Ilika's recent success in attracting funding to support its work in developing advanced aerospace alloys. Last week, we announced that Ilika had been awarded a £466,000 grant to support its role leading a £2.15 million, 3-year collaborative project with Reliance, the University of Sheffield, GKN and BAE Systems. The project will develop a new generation of self-healing alloys for additive manufacturing (AM) processes. Forecasts for the AM market (also known as 3D printing) fall into the $230 bn- $550 bn range by 2025 and developing suitable alloys for this process will be a valuable enabling technology.

 

This AGM will also be a time of board renewal, with the retirement of Jack Boyer OBE after 11 years in the role and his replacement, pending shareholder confirmation, by Mike Inglis. Jack has overseen the growth of the company from a University spin-out in 2004, through three rounds of venture finance and a successful IPO in 2010. Mike brings a wealth of IP commercialisation experience to the board, from his time as Commercial Director at ARM Holdings. Mike's appointment builds on the addition of Professor Keith Jackson to the board in October 2014. This development of the board is part of a broader transition for Ilika from a project-based organisation to one with a greater product focus and we'd like to thank our shareholders for their continued support and enthusiasm during this period.

 

 

 

For more information contact:

 

Ilika plc

www.ilika.com

Graeme Purdy, Chief Executive

Tel: 023 8011 1400

Steve Boydell, Finance Director

 

 

 

Numis Securities Limited

Tel: 020 7260 1000

Oliver Cardigan/ Adrian Trimmings /

 

James Black

 

 

 

Walbrook PR Ltd

Tel: 020 7933 8780 / ilika@walbrookpr.com

Paul McManus

Mob: 07980 541 893

Lianne Cawthorne

Mob: 07584 391 303

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
AGMPKCDQPBKDQCB
Date   Source Headline
19th Dec 20224:35 pmRNSPrice Monitoring Extension
16th Dec 20224:40 pmRNSSecond Price Monitoring Extn
16th Dec 20224:35 pmRNSPrice Monitoring Extension
21st Nov 20221:29 pmEQSIlika 'well positioned' to deliver battery product combination
17th Nov 20224:40 pmRNSSecond Price Monitoring Extn
17th Nov 20224:35 pmRNSPrice Monitoring Extension
17th Nov 20229:05 amRNSSecond Price Monitoring Extn
17th Nov 20229:00 amRNSPrice Monitoring Extension
17th Nov 20227:01 amRNSAppointment of Chief Financial Officer
17th Nov 20227:00 amRNSTrading Update, Notice of Results & Presentations
22nd Sep 202212:45 pmRNSExercise of Options, PDMR Shareholding and TVR
20th Sep 20224:47 pmRNSResult of AGM
7th Sep 202210:00 amRNSGoliath Scale-up Update
18th Aug 20227:00 amRNSPosting of Annual Report and Notice of AGM
1st Aug 20229:05 amRNSSecond Price Monitoring Extn
1st Aug 20229:00 amRNSPrice Monitoring Extension
25th Jul 20223:30 pmRNSHolding(s) in Company
20th Jul 20222:05 pmRNSSecond Price Monitoring Extn
20th Jul 20222:00 pmRNSPrice Monitoring Extension
14th Jul 20227:00 amRNSExercise of Options and Total Voting Rights
13th Jul 20224:41 pmRNSSecond Price Monitoring Extn
13th Jul 20224:36 pmRNSPrice Monitoring Extension
13th Jul 20227:00 amRNSFinal Results
20th Jun 20227:00 amRNSGoliath Scale-up Update
11th May 20227:00 amRNSTrading Update & Notice of Results
4th May 20227:00 amRNSGoliath Scale-up Update
21st Mar 202211:45 amRNSDirector/PDMR Shareholding
15th Mar 202212:34 pmRNSDirector/PDMR Shareholding
25th Feb 20227:00 amRNSDirectorate Change
24th Feb 20222:01 pmRNSPrice Monitoring Extension
8th Feb 20227:00 amRNSAward of Share Options
7th Feb 202211:01 amRNSPrice Monitoring Extension
20th Jan 20227:00 amRNSHalf-year Report
6th Dec 20217:00 amRNSFirst Stereax Manufacturing Facility Opened
23rd Nov 20215:11 pmRNSHolding(s) in Company
19th Nov 20217:00 amRNSTrading Update & Notice of Half-year Results
10th Nov 20217:00 amRNSCapital Markets Day
22nd Sep 20213:30 pmRNSResult of AGM and Award of Bonus Share Options
10th Sep 20217:00 amRNSCommencement of trading on OTCQX Best Market in US
7th Sep 20217:00 amRNSSenior Appointments and Change of Director
24th Aug 20217:00 amRNSStereax Manufacturing Update
20th Aug 20217:00 amRNSNotice of AGM & Posting of Annual Report
5th Aug 20219:16 amRNSExercise of Options and Total Voting Rights
30th Jul 20214:32 pmRNSHolding(s) in Company
30th Jul 20219:54 amRNSDirector/PDMR Shareholding
29th Jul 20219:00 amRNSExercise of Options and Total Voting Rights
28th Jul 20211:14 pmRNSResults of GM, Open Offer and Total Voting Rights
12th Jul 202112:30 pmRNSPosting of Circular
9th Jul 20214:07 pmRNSResult of Placing and Retail Offer
9th Jul 20217:01 amRNSRetail Offer

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.